Cost and efficacy analysis in the ESVEM trial: Implications for diagnosis and therapy for ventricular tachyarrhythmias

Progress in Cardiovascular Diseases

Volumn 38, Issue 5, 1996, Pages 371-376

  Hlatky, M A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; ELECTROCARDIOGRAM; FOLLOW UP; HEALTH CARE COST; HEART VENTRICLE TACHYCARDIA; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029997502     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(96)80030-2     Document Type: Article

References (12)

1. Finkler SA The distinction between costs and charges Ann Intern Med 96 1982 102 110
2. Hlatky MA Lipscomb J Nelson C Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery Circulation 82 suppl IV 1990 208 213
3. Dudley RA Harrell FE Smith LR Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery J Clin Epidemiol 46 1993 261 271
4. Mason JW ESVEM Investigators A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias N Engl J Med 329 1993 445 451
5. Mason JW ESVEM Investigators A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias N Engl J Med 329 1993 452 458
6. Omoigui NA Marcus FI Mason JW Cost of initial therapy in the Electrophysiologic Study Versus ECG Monitoring trial (ESVEM) Circulation 91 1995 1070 1076
7. Connolly SJ Gent M Roberts RS Canadian Implantable Defibrillator Study (CIDS): Study design and organization Am J Cardiol 72 1993 103F 108F
8. AVID Investigators Antiarrhythmics Versus Implantable Defibrillators (AVID)—Rationale, design, and methods Am J Cardiol 75 1995 470 475
9. MADIT Executive Committee Multicenter Automatic Defibrillator Implantation Trial (MADIT): Design and clinical protocol PACE 14 1991 920 927
10. Reeder GS Krishan I Nobrega FT Is percutaneous coronary angioplasty less expensive than bypass surgery? N Engl J Med 311 1984 1157 1162
11. Hlatky MA, Boothroyd DB, Johnstone IM, et al: Long-term cost-effectiveness of alternative management strategies for life threatening ventricular arrhythmias. J Clin Epidemiol (in press)
12. Kupersmith J Holmes-Rovner M Hogan A Cost-effectiveness analysis in heart disease, Part I: General principles Prog Cardiovasc Dis 37 1994 161 184